Novel strategies to overcome chemoresistance in human glioblastoma
Q Tang, T Ren, P Bai, X Wang, L Zhao, R Zhong… - Biochemical …, 2024 - Elsevier
Temozolomide (TMZ) is currently the first-line chemotherapeutic agent for the treatment of
glioblastoma multiforme (GBM). However, the inherent heterogeneity of GBM often results in …
glioblastoma multiforme (GBM). However, the inherent heterogeneity of GBM often results in …
New Targeting Opportunities in Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastoma
E Martinez-Jaramillo - 2023 - search.proquest.com
Abstract Isocitrate Dehydrogenase (IDH)-wildtype Glioblastoma (GBM) is the most common
and aggressive malignant primary brain tumour in adults, it has a very poor prognosis with a …
and aggressive malignant primary brain tumour in adults, it has a very poor prognosis with a …